Display options
Cite
He G, Cao X, He M, et al. Casticin inhibits self-renewal of liver cancer stem cells from the MHCC97 cell line. Oncol Lett. 2014;7(6):2023-2028doi: 10.3892/ol.2014.1972.
He, G., Cao, X., He, M., Sheng, X., Wu, Y., & Ai, X. (2014). Casticin inhibits self-renewal of liver cancer stem cells from the MHCC97 cell line. Oncology letters, 7(6), 2023-2028. https://doi.org/10.3892/ol.2014.1972
He, Guicheng, et al. "Casticin inhibits self-renewal of liver cancer stem cells from the MHCC97 cell line." Oncology letters vol. 7,6 (2014): 2023-2028. doi: https://doi.org/10.3892/ol.2014.1972
He G, Cao X, He M, Sheng X, Wu Y, Ai X. Casticin inhibits self-renewal of liver cancer stem cells from the MHCC97 cell line. Oncol Lett. 2014 Jun;7(6):2023-2028. doi: 10.3892/ol.2014.1972. Epub 2014 Mar 14. PMID: 24932283; PMCID: PMC4049684.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2014 Jun;7(6):2023-2028. doi: 10.3892/ol.2014.1972. Epub 2014 Mar 14.

Casticin inhibits self-renewal of liver cancer stem cells from the MHCC97 cell line.

Oncology letters

Guicheng He, Xiaocheng Cao, Meng He, Xifeng Sheng, Youhua Wu, Xiaohong Ai

Affiliations

  1. Department of Oncology, First Affiliated Hospital of University of South China, Hengyang, Hunan 421001, P.R. China.
  2. Medical College, Hunan Normal University, Changsha, Hunan 410013, P.R. China.

PMID: 24932283 PMCID: PMC4049684 DOI: 10.3892/ol.2014.1972

Abstract

Casticin exerts anticarcinogenic activity in several types of cancers, including human hepatocellular carcinoma (HCC). The aim of the present study was to investigate the effects of casticin, which is derived from

Keywords: cancer stem cells; casticin; hepatocellular carcinoma; self-renewal; β-catenin

References

  1. Mol Pharm. 2009 May-Jun;6(3):959-70 - PubMed
  2. J Natl Cancer Inst. 1983 Jan;70(1):9-16 - PubMed
  3. Liver Int. 2009 Aug;29(7):955-65 - PubMed
  4. Cancer Lett. 2004 May 10;208(1):59-64 - PubMed
  5. Cancer Sci. 2010 Oct;101(10):2145-55 - PubMed
  6. Mol Med Rep. 2012 Nov;6(5):1117-20 - PubMed
  7. J Clin Invest. 2010 Sep;120(9):3326-39 - PubMed
  8. Oncogene. 2012 Aug 23;31(34):3901-12 - PubMed
  9. Cancer Lett. 2009 Mar 18;275(2):185-93 - PubMed
  10. J Pathol. 2008 Jan;214(1):3-9 - PubMed
  11. Ann Hematol. 2009 Aug;88(8):743-52 - PubMed
  12. Cancer Cell. 2008 Feb;13(2):153-66 - PubMed
  13. Acta Pharmacol Sin. 2010 Dec;31(12):1564-8 - PubMed
  14. World J Gastroenterol. 2011 Oct 14;17(38):4298-307 - PubMed
  15. J Biomed Biotechnol. 2012;2012:950658 - PubMed
  16. J Gastrointestin Liver Dis. 2010 Mar;19(1):61-7 - PubMed
  17. Nature. 2007 Jan 4;445(7123):111-5 - PubMed
  18. Stem Cell Rev. 2008 Sep;4(3):179-92 - PubMed
  19. Nat Med. 2009 Sep;15(9):1010-2 - PubMed
  20. Gastroenterology. 2007 Jun;132(7):2542-56 - PubMed
  21. Cancer Res. 2008 Jun 1;68(11):4287-95 - PubMed
  22. Drug Resist Updat. 2010 Aug-Oct;13(4-5):109-18 - PubMed
  23. PLoS One. 2012;7(12):e50638 - PubMed
  24. Int J Cancer. 2010 May 1;126(9):2067-78 - PubMed
  25. Cell Stem Cell. 2010 Dec 3;7(6):694-707 - PubMed
  26. Eur Respir J. 2008 Mar;31(3):681-2 - PubMed
  27. Hepatology. 2006 Jul;44(1):240-51 - PubMed

Publication Types